Loading the section…
The price of AC Immune SA (ACIU) on October 9, 2026 is 2.50 USD, -1.96% on the day. Over 52 weeks the stock traded between 2.10 USD and 4.00 USD; the price now sits 21% of the way up that range. Over the past year the price changed by -28.98%.
Closing prices for 9 October 2026
Next earnings report: 3 November 2026 · Earnings calendar
Change over the period shown (line colour): −27.95 %
AC Immune SA trades on Nasdaq under the ticker ACIU. The company belongs to the Health care sector. The trading history on this page starts on 23 September 2016.
Over the past 52 weeks ACIU has traded between 2.10 $ and 4.00 $. As of 9 October 2026 the price stood 21.26 % of the way from the 52-week low to the high.
Over one year ACIU shares fell 28.98 %; over six months they fell 23.78 %. Volatility over 90 days is 60.24 %. Dividends are not included: this is price change only, as of 9 October 2026.
AC Immune SA reported revenue of 4M CHF and a net loss of 70M CHF for the latest fiscal year. Net margin is −1,971.65 %. Revenue changed by −86.92 % year over year. Earnings per share are −0.70 CHF.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 2.55 | 2.59 | 2.48 | 2.50 | 271,300 |
| 8 October 2026 | 2.57 | 2.61 | 2.50 | 2.55 | 231,900 |
| 7 October 2026 | 2.52 | 2.59 | 2.50 | 2.57 | 125,100 |
| 6 October 2026 | 2.72 | 2.72 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
No news about this security in English yet.
Address:EPFL INNOVATION PARK, BUILDING B, 1015 LAUSANNE, 00000, CH
ACIU has a return on equity of −156.95 %, below the sector median of −41.68 %. Return on assets is −45.67 %, below the sector median of −32.11 %. Operating margin is −1,940.05 %, below the sector median of −26.84 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 2.51 |
| 2.52 |
| 277,800 |
| 5 October 2026 | 2.68 | 2.75 | 2.65 | 2.71 | 221,400 |
| 2 October 2026 | 2.84 | 2.88 | 2.69 | 2.73 | 320,200 |
| 1 October 2026 | 2.64 | 2.84 | 2.57 | 2.81 | 352,700 |
| 30 September 2026 | 2.63 | 2.75 | 2.61 | 2.62 | 199,600 |
| 29 September 2026 | 2.65 | 2.66 | 2.56 | 2.60 | 134,200 |
| 28 September 2026 | 2.52 | 2.62 | 2.41 | 2.61 | 188,900 |
| 25 September 2026 | 2.66 | 2.66 | 2.45 | 2.52 | 323,600 |
| 24 September 2026 | 2.85 | 2.85 | 2.66 | 2.66 | 265,300 |
| 23 September 2026 | 2.90 | 2.91 | 2.67 | 2.83 | 491,800 |
| 22 September 2026 | 2.69 | 2.75 | 2.66 | 2.73 | 78,100 |
| 21 September 2026 | 2.63 | 2.72 | 2.57 | 2.66 | 109,400 |
| 18 September 2026 | 2.69 | 2.81 | 2.63 | 2.63 | 68,500 |
| 17 September 2026 | 2.71 | 2.74 | 2.66 | 2.68 | 93,300 |
| 16 September 2026 | 2.68 | 2.73 | 2.61 | 2.65 | 124,400 |
| 15 September 2026 | 2.65 | 2.70 | 2.59 | 2.68 | 93,500 |
| 14 September 2026 | 2.69 | 2.75 | 2.66 | 2.66 | 111,800 |